DCK and neoplasm: In addition, DCK upregulation in tumor cells may indicate a minimized 5hmdC toxicity for normal tissues in which DCK expression is relatively low, consistent with the lack of discernible adverse effects on cord blood-derived CD34+ cells and in mice administered with 5hmdC.